CA1240930A - Process for producing an injection of nicardipine hydrochloride - Google Patents
Process for producing an injection of nicardipine hydrochlorideInfo
- Publication number
- CA1240930A CA1240930A CA000481975A CA481975A CA1240930A CA 1240930 A CA1240930 A CA 1240930A CA 000481975 A CA000481975 A CA 000481975A CA 481975 A CA481975 A CA 481975A CA 1240930 A CA1240930 A CA 1240930A
- Authority
- CA
- Canada
- Prior art keywords
- injection
- nicardipine hydrochloride
- polyhydric alcohol
- nicardipine
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002347 injection Methods 0.000 title claims abstract description 56
- 239000007924 injection Substances 0.000 title claims abstract description 56
- 238000000034 method Methods 0.000 title claims abstract description 25
- 229960002289 nicardipine hydrochloride Drugs 0.000 title claims abstract description 25
- AIKVCUNQWYTVTO-UHFFFAOYSA-N nicardipine hydrochloride Chemical compound Cl.COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 AIKVCUNQWYTVTO-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 239000000243 solution Substances 0.000 claims abstract description 21
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 27
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 17
- 239000000600 sorbitol Substances 0.000 claims description 17
- 235000010356 sorbitol Nutrition 0.000 claims description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 10
- 229930195725 Mannitol Natural products 0.000 claims description 10
- 239000000594 mannitol Substances 0.000 claims description 10
- 235000010355 mannitol Nutrition 0.000 claims description 10
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 4
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 4
- 229960000367 inositol Drugs 0.000 claims description 4
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims 2
- 235000013772 propylene glycol Nutrition 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 3
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 238000009472 formulation Methods 0.000 abstract description 2
- 230000002792 vascular Effects 0.000 abstract description 2
- 229940090044 injection Drugs 0.000 description 45
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- ZBBHBTPTTSWHBA-UHFFFAOYSA-N Nicardipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OCCN(C)CC=2C=CC=CC=2)C1C1=CC=CC([N+]([O-])=O)=C1 ZBBHBTPTTSWHBA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960001783 nicardipine Drugs 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- RWNNRGBCWXOVAC-UHFFFAOYSA-N 1,4-bis[bis(aziridin-1-yl)phosphoryl]piperazine Chemical compound C1CN1P(N1CCN(CC1)P(=O)(N1CC1)N1CC1)(=O)N1CC1 RWNNRGBCWXOVAC-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001547070 Eriodes Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- -1 ~ylitol Chemical compound 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP102991/1984 | 1984-05-22 | ||
| JP59102991A JPS60246313A (ja) | 1984-05-22 | 1984-05-22 | 塩酸ニカルジピンの注射剤およびその製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1240930A true CA1240930A (en) | 1988-08-23 |
Family
ID=14342164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000481975A Expired CA1240930A (en) | 1984-05-22 | 1985-05-21 | Process for producing an injection of nicardipine hydrochloride |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4880823A (forum.php) |
| EP (1) | EP0162705B1 (forum.php) |
| JP (1) | JPS60246313A (forum.php) |
| KR (1) | KR910003555B1 (forum.php) |
| AT (1) | ATE63810T1 (forum.php) |
| CA (1) | CA1240930A (forum.php) |
| DE (1) | DE3582954D1 (forum.php) |
| ES (1) | ES8700567A1 (forum.php) |
| GR (1) | GR851230B (forum.php) |
| MX (1) | MX9203588A (forum.php) |
| PT (1) | PT80486B (forum.php) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5210083A (en) * | 1986-07-17 | 1993-05-11 | Ed. Geistlich Sohne A.G. Fur Chemische Industrie | Pharmaceutical compositions |
| GB8617482D0 (en) * | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| JPH0696533B2 (ja) * | 1987-01-14 | 1994-11-30 | 北陸製薬株式会社 | キノロンカルボン酸の水性組成物 |
| YU45837B (sh) * | 1988-01-18 | 1992-07-20 | LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. | Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom |
| BE1003647A5 (fr) * | 1989-02-28 | 1992-05-12 | Syntex Inc | Composition pharmaceutique de nicardipine pour administration parenterale. |
| WO1998001138A1 (fr) * | 1996-07-04 | 1998-01-15 | Nippon Kayaku Kabushiki Kaisha | Injections de succinate sodique de methylprednisolone |
| US20070112041A1 (en) * | 2005-11-16 | 2007-05-17 | Sun Pharmaceutical Industries Limited | Nicardipine injection composition |
| BRPI0710287A2 (pt) * | 2006-04-18 | 2012-05-29 | Ekr Therapeutics Inc | composição farmacêutica, método para tratar um indivìduo quanto à pressão sangüìnea elevada, complexo de inclusão, e, métodos para tratar e evitar elevações agudas da pressão sangüinea em um indivìduo humano e para induzir a hipotensão em um indivìduo humano. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3720761A (en) * | 1968-10-14 | 1973-03-13 | W Hunter | Injectable radio-pharmaceutical scanning agent and preparation |
| DE2935451A1 (de) * | 1979-09-01 | 1981-03-19 | Bayer Ag, 5090 Leverkusen | Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel |
| DE3023495C2 (de) * | 1980-06-24 | 1982-04-08 | Kienzle Apparate Gmbh, 7730 Villingen-Schwenningen | Diagrammauswertegerät für die Unfalldiagrammauswertung von Fahrtschreiber-Diagrammen |
| JPS57167967A (en) * | 1981-04-08 | 1982-10-16 | Yoshitomi Pharmaceut Ind Ltd | 1,4-dihydropyridine-3,5-dicarboxylic acid ester or its salt |
| DE3205504C2 (de) * | 1982-02-16 | 1983-12-01 | Dolorgiet Gmbh & Co Kg, 5300 Bonn | Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel |
| JPS58172312A (ja) * | 1982-04-02 | 1983-10-11 | Toa Eiyou Kagaku Kogyo Kk | ニフエジピン外用剤 |
| DE3212736A1 (de) * | 1982-04-06 | 1983-10-13 | Bayer Ag, 5090 Leverkusen | Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung |
| DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
| DE3316510A1 (de) * | 1983-05-06 | 1984-11-08 | Bayer Ag | Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen |
| JPS6016917A (ja) * | 1983-07-08 | 1985-01-28 | Yamanouchi Pharmaceut Co Ltd | 塩酸ニカルジピンまたはニフエジピンの軟膏剤 |
-
1984
- 1984-05-22 JP JP59102991A patent/JPS60246313A/ja active Granted
-
1985
- 1985-05-17 PT PT80486A patent/PT80486B/pt unknown
- 1985-05-20 KR KR1019850003448A patent/KR910003555B1/ko not_active Expired
- 1985-05-20 GR GR851230A patent/GR851230B/el unknown
- 1985-05-21 CA CA000481975A patent/CA1240930A/en not_active Expired
- 1985-05-21 DE DE8585303588T patent/DE3582954D1/de not_active Expired - Lifetime
- 1985-05-21 AT AT85303588T patent/ATE63810T1/de not_active IP Right Cessation
- 1985-05-21 EP EP85303588A patent/EP0162705B1/en not_active Expired - Lifetime
- 1985-05-21 ES ES543343A patent/ES8700567A1/es not_active Expired
-
1989
- 1989-04-12 US US07/338,402 patent/US4880823A/en not_active Ceased
-
1992
- 1992-06-26 MX MX9203588A patent/MX9203588A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US4880823A (en) | 1989-11-14 |
| JPS60246313A (ja) | 1985-12-06 |
| GR851230B (forum.php) | 1985-11-25 |
| PT80486B (en) | 1986-12-12 |
| EP0162705A3 (en) | 1987-01-28 |
| KR850008278A (ko) | 1985-12-16 |
| PT80486A (en) | 1985-06-01 |
| ES543343A0 (es) | 1986-10-16 |
| EP0162705A2 (en) | 1985-11-27 |
| MX9203588A (es) | 1992-07-31 |
| DE3582954D1 (de) | 1991-07-04 |
| ATE63810T1 (de) | 1991-06-15 |
| ES8700567A1 (es) | 1986-10-16 |
| JPH0247964B2 (forum.php) | 1990-10-23 |
| EP0162705B1 (en) | 1991-05-29 |
| KR910003555B1 (ko) | 1991-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0243308B1 (de) | Stabilisierung des Konservierungsmittels Thiomersal in Augenarzneimitteln | |
| CA1276113C (en) | Effervescent composition with analgesic activity | |
| RU2192249C2 (ru) | Жидкая стабильная композиция на основе парацетамола и способ ее получения | |
| KR920003331B1 (ko) | 활성성분으로 스페르구알린(Spergualin)을 함유하는 주사제 조성물과 그 제조방법. | |
| US5017609A (en) | Pharmaceutical composition and method of treatment or prophylaxis of cardiac disorders | |
| CA1240930A (en) | Process for producing an injection of nicardipine hydrochloride | |
| JP3043381B2 (ja) | 葉酸及びロイコボリン塩類の安定で注射液として使用できる薬剤及びその製造方法 | |
| EP0143478A1 (en) | Stable, aqueous, acidic solution of cis-platinum, suitable for injection | |
| US5223515A (en) | Injectable solution containing a pyridyl methylsulfinylbenzimidazole | |
| EP0356143B1 (en) | Injectable solutions | |
| JPS6416724A (en) | Stable and injectable vinca dimer salt solution | |
| US6020359A (en) | Pharmaceutical composition | |
| SK53597A3 (en) | A storage stable water solution for infusion containing a thrombin inhibitor | |
| RU1828401C (ru) | Способ получени противоопухолевого средства | |
| USRE34618E (en) | Injection of nicardinpine hydrochloride and process for the production thereof | |
| EP0038013B1 (en) | Injectable oxytetracycline compositions | |
| WO2002026233B1 (de) | Lagerstabile infusionslösung des ciprofloxacins mit verringertem säuregehalt | |
| CS226417B2 (en) | Parenteral solvent for preparing injectable solutions | |
| US4399127A (en) | Injectable oxytetracycline compositions | |
| US20030157046A1 (en) | Minoxidil-containing preparations | |
| US4386083A (en) | Injectable oxytetracycline compositions | |
| KR100525058B1 (ko) | 광안정성을 높인 수성 약제학적 조성물 및 광안정화 방법 | |
| JPS5989616A (ja) | 点眼液 | |
| HU211477A9 (hu) | Bisz-indol-alkaloid-sót tartalmazó injekciós oldat | |
| AU1134500A (en) | 'Soluble 2-chloro-2'-deoxyadenosine formulations' |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |